SOD2-OT1: A Drug Target / Disease Biomarker (G100129518)

Target Name: SOD2-OT1

NCBI ID: G100129518

SOD2-OT1

Other Name(s): SOD2 | SOD2 overlapping transcript 1

SOD2-OT1: A Drug Target / Disease Biomarker

SOD2-OT1 is a protein that is expressed in the liver and is involved in the detoxification of a class of drugs called heterodienes. These drugs can cause toxic effects on the liver, and SOD2-OT1 is thought to play a role in protecting the liver from these drugs.

SOD2-OT1 is a member of a family of proteins called superoxide dismutases (SDs), which are enzymes that help to protect cells from the harmful effects of reactive oxygen species (ROS). In the liver, ROS can be generated by the breakdown of certain types of drugs, such as

Protein Name: SOD2 Overlapping Transcript 1

The "SOD2-OT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SOD2-OT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets